About
Wesley Wierson is a scientist and entrepreneur with expertise in gene editing who founded LEAH Labs to develop cancer therapies using CAR-T technology in veterinary settings, which he identified as a pathway to market with lighter regulatory requirements than human therapeutics.
Wesley Wierson @dna4cy
I told my 4 year old daughter I talk to robots all day. Wish I could replay the look on her face forever. She thinks that's pretty cool, but didn't quite understand how they live on a computer and aren't humanoids (yet). Then she saw the rainbow lights on our GPU and it didn't https://t.co/7yMIOP7ZD7
Jun 18, 2026 Β· β₯ 1
Wesley Wierson @dna4cy
LLMs hallucinate. Our @openclaw agentic fleet doesn't. We published a paper about the emergent behavior one of our agents showed, and how we propagated this through our fleet towards "AI Science, With Trust". We now beat state-of-the-art labs on hallucination detection. https://t.co/00ulYFAaam
Mar 30, 2026 Β· β₯ 2 Β· β 2
Wesley Wierson @dna4cy
Our first paper out from @LEAHLabsInc in collaboration with UT-Austin scientists. Open source de novo design of antigen receptors for CAR-T cell therapy. 42 countries of teams. 12,000 binders screened. Dozens of CD20 binders that enable functional CAR-T cells identified. And a https://t.co/46y045qf8w
Mar 4, 2026 Β· β₯ 4 Β· β 1
Founder at LEAH LabsYC W19
Intro paths
Wesley went through Y Combinator (Winter 2019) β any YC alum in your network can reach them through the YC community.
In turn, Wesley can intro founders to LEAH Labs's investors below.